Walleye Trading’s Filana Therapeutics FLNA Stock Holding History
Bought
Maintained
Sold
Other funds holding FLNA
VCM
GC
Walleye Trading's FLNA Position: Q1 2026 in Review
Walleye Trading increased its Filana Therapeutics (FLNA) stake by 128% in Q1 2026, buying an estimated $24.3K and bringing the position to 20,968 shares worth $35.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3759.
Walleye Trading first reported a position in FLNA in Q2 2016 and has held it in 9 quarters since. The position peaked at $662K in Q2 2023. 101 funds tracked by Wall St. Rank hold FLNA as of Q1 2026.
- Walleye Trading held 20,968 shares of Filana Therapeutics worth $35.4K as of Q1 2026.
- Walleye Trading bought 11,790 Filana Therapeutics shares in Q1 2026, an estimated $24.3K.
- Filana Therapeutics made up ﹤0.01% of Walleye Trading's portfolio in Q1 2026, its #3759 holding.
- Walleye Trading first reported a position in Filana Therapeutics in Q2 2016 and has held it in 9 quarters since.
- Walleye Trading's Filana Therapeutics position peaked at $662K in Q2 2023.
- 101 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2026.
Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.